Co-Authors
This is a "connection" page, showing publications co-authored by Giacomo De Riu and Luigi Vaira.
Connection Strength
23.887
-
Specific Therapy of Olfactory Disorders in COVID-19 Patients is Essential for the Prevention of Long-term Dysfunction. Indian J Otolaryngol Head Neck Surg. 2021 Aug 22; 1-2.
Score: 0.963
-
Secondary thrombocytopenia after SARS-CoV-2 vaccine: Report of a case of hemorrhage and hematoma after minor oral surgery. J Stomatol Oral Maxillofac Surg. 2021 Jul 24.
Score: 0.958
-
Systemic inflammatory markers and psychophysical olfactory scores in coronavirus disease 2019 patients: is there any correlation? J Laryngol Otol. 2021 Aug; 135(8):723-728.
Score: 0.953
-
Correlations between IL-6 serum level and olfactory dysfunction severity in COVID-19 patients: a preliminary study. Eur Arch Otorhinolaryngol. 2022 Feb; 279(2):811-816.
Score: 0.945
-
Efficacy of corticosteroid therapy in the treatment of long- lasting olfactory disorders in COVID-19 patients. Rhinology. 2021 Feb 01; 59(1):21-25.
Score: 0.927
-
Olfactory epithelium histopathological findings in long-term coronavirus disease 2019 related anosmia. J Laryngol Otol. 2020 Dec; 134(12):1123-1127.
Score: 0.914
-
Gustatory Dysfunction: A Highly Specific and Smell-Independent Symptom of COVID-19. Indian J Otolaryngol Head Neck Surg. 2020 Sep 30; 1-3.
Score: 0.906
-
Reader response: Miller Fisher syndrome and polyneuritis cranialis in COVID-19. Neurology. 2020 08 25; 95(8):368-369.
Score: 0.899
-
Smell and taste recovery in coronavirus disease 2019 patients: a 60-day objective and prospective study. J Laryngol Otol. 2020 Aug; 134(8):703-709.
Score: 0.897
-
Do olfactory and gustatory psychophysical scores have prognostic value in COVID-19 patients? A prospective study of 106 patients. J Otolaryngol Head Neck Surg. 2020 Aug 06; 49(1):56.
Score: 0.896
-
In Response to Anosmia and Ageusia: Common Findings in COVID-19 Patients. Laryngoscope. 2020 11; 130(11):E695.
Score: 0.893
-
In Response to: In Reference to Anosmia and Ageusia: Common Findings in COVID-19 Patients. Laryngoscope. 2020 09; 130(9):E506.
Score: 0.890
-
In Response to Isolated Anosmia and Ageusia in COVID-19 With Spontaneous Recovery. Laryngoscope. 2020 09; 130(9):E503.
Score: 0.887
-
Potential pathogenesis of ageusia and anosmia in COVID-19 patients. Int Forum Allergy Rhinol. 2020 09; 10(9):1103-1104.
Score: 0.887
-
Olfactory and gustatory function impairment in COVID-19 patients: Italian objective multicenter-study. Head Neck. 2020 Jul; 42(7):1560-1569.
Score: 0.883
-
Validation of a self-administered olfactory and gustatory test for the remotely evaluation of COVID-19 patients in home quarantine. Head Neck. 2020 Jul; 42(7):1570-1576.
Score: 0.881
-
Objective evaluation of anosmia and ageusia in COVID-19 patients: Single-center experience on 72 cases. Head Neck. 2020 06; 42(6):1252-1258.
Score: 0.879
-
The importance of olfactory and gustatory disorders as early symptoms of coronavirus disease (COVID-19). Br J Oral Maxillofac Surg. 2020 06; 58(5):615-616.
Score: 0.879
-
Anosmia and Ageusia: Common Findings in COVID-19 Patients. Laryngoscope. 2020 07; 130(7):1787.
Score: 0.877
-
Tactile recovery assessment with shortened Semmes-Weinstein monofilaments in patients with buccinator myomucosal flap oral cavity reconstructions. Oral Maxillofac Surg. 2018 Jun; 22(2):151-156.
Score: 0.753
-
Accuracy of computer-assisted orthognathic surgery. J Craniomaxillofac Surg. 2018 Feb; 46(2):293-298.
Score: 0.745
-
Complications and post-operative sequelae of temporomandibular joint arthrocentesis. Cranio. 2018 Jul; 36(4):264-267.
Score: 0.721
-
Aesthetic and Functional Evaluation of Total Nasal Reconstructions. Indian J Otolaryngol Head Neck Surg. 2018 Mar; 70(1):71-78.
Score: 0.700
-
Correlations Between Olfactory Psychophysical Scores and SARS-CoV-2 Viral Load in COVID-19 Patients. Laryngoscope. 2021 10; 131(10):2312-2318.
Score: 0.239
-
Analysis of the correlations between the severity of lung involvement and olfactory psychophysical scores in coronavirus disease 2019 (COVID-19) patients. Int Forum Allergy Rhinol. 2022 01; 12(1):103-107.
Score: 0.239
-
Six-month smell and taste recovery rates in coronavirus disease 2019 patients: a prospective psychophysical study. J Laryngol Otol. 2021 May; 135(5):436-441.
Score: 0.235
-
Chemosensory dysfunction in COVID-19: Is there really a correlation with viral load? Am J Otolaryngol. 2021 Jul-Aug; 42(4):103037.
Score: 0.235
-
Psychophysical Evaluation of the Olfactory Function: European Multicenter Study on 774 COVID-19 Patients. Pathogens. 2021 Jan 12; 10(1).
Score: 0.231
-
Ageusia, a highly specific symptom of COVID-19, for which an unaware patient may seek dental assistance. Int Dent J. 2020 Sep 22.
Score: 0.226
-
Remote psychophysical evaluation of olfactory and gustatory functions in early-stage coronavirus disease 2019 patients: the Bologna experience of 300 cases. J Laryngol Otol. 2020 Jul; 134(7):571-576.
Score: 0.224
-
Anosmia: a COVID-19 symptom that must be investigated by rhinoplasty surgeons. Eur J Plast Surg. 2020; 43(6):865-866.
Score: 0.223
-
Self-reported olfactory loss in COVID-19: is it really a favorable prognostic factor? Int Forum Allergy Rhinol. 2020 07; 10(7):926.
Score: 0.222
-
Comment on: Facial Artery Myomucosal Flap, Pedicled Solely on the Facial Artery: Experimental Design Study on Survival. J Craniofac Surg. 2018 05; 29(3):809.
Score: 0.191
-
Reconstruction of full-thickness cheek defect with chimeric facial artery free flap: A case report. Microsurgery. 2018 May; 38(4):427-431.
Score: 0.186
-
Soft palate functional reconstruction with buccinator myomucosal island flaps. Int J Oral Maxillofac Surg. 2018 Mar; 47(3):316-323.
Score: 0.186
-
Sensory recovery of myomucosal flap oral cavity reconstructions. Head Neck. 2018 03; 40(3):467-474.
Score: 0.185
-
Rational and simplified nomenclature for buccinator myomucosal flaps. Oral Maxillofac Surg. 2017 Dec; 21(4):453-459.
Score: 0.184
-
Islanded facial artery musculomucosal flap for tongue reconstruction. Int J Oral Maxillofac Surg. 2017 08; 46(8):1060-1061.
Score: 0.178
-
Correction to: Epidemiological, otolaryngological, olfactory and gustatory outcomes according to the severity of COVID-19: a study of 2579 patients. Eur Arch Otorhinolaryngol. 2021 Aug; 278(8):2861.
Score: 0.060
-
Predictive factors of smell recovery in a clinical series of 288 coronavirus disease 2019 patients with olfactory dysfunction. Eur J Neurol. 2021 11; 28(11):3702-3711.
Score: 0.060
-
Short-Term Efficacy and Safety of Oral and Nasal Corticosteroids in COVID-19 Patients with Olfactory Dysfunction: A European Multicenter Study. Pathogens. 2021 Jun 04; 10(6).
Score: 0.059
-
Have There Been any Changes in the Epidemiology and Etiology of Maxillofacial Trauma During the COVID-19 Pandemic? An Italian Multicenter Study. J Craniofac Surg. 2021 Jun 01; 32(4):1445-1447.
Score: 0.059
-
Facing COVID-19 pandemic: development of custom-made face mask with rapid prototyping system. J Infect Dev Ctries. 2021 Jan 31; 15(1):51-57.
Score: 0.058
-
Epidemiological, otolaryngological, olfactory and gustatory outcomes according to the severity of COVID-19: a study of 2579 patients. Eur Arch Otorhinolaryngol. 2021 Aug; 278(8):2851-2859.
Score: 0.058
-
Severity of Anosmia as an Early Symptom of COVID-19 Infection May Predict Lasting Loss of Smell. Front Med (Lausanne). 2020; 7:582802.
Score: 0.057
-
Clinical and Radiological Evaluations of COVID-19 Patients With Anosmia: Preliminary Report. Laryngoscope. 2020 11; 130(11):2526-2531.
Score: 0.056
-
Objective Olfactory Findings in Hospitalized Severe COVID-19 Patients. Pathogens. 2020 Jul 31; 9(8).
Score: 0.056
-
The epidemiological analysis of maxillofacial fractures in Italy: The experience of a single tertiary center with 1720 patients. J Craniomaxillofac Surg. 2017 Aug; 45(8):1319-1326.
Score: 0.045